Amber Group Unveils Full Product Suite
2020-11-04
News.Yahoo
HONG KONG -- Amber Group (www.ambergroup.io), a leading global crypto finance service provider, unveiled their new product suite at a press conference on October 20, 2020. Chief Executive Officer and Co-founder Michael Wu, together with Chief Product Officer Annabelle Huang, revealed how the Company is repositioning to focus on democratizing access to crypto finance.
From pure-play to integrated crypto finance services
Founded in 2017, Amber Group is trusted by over 200 institutional clients and remains one of Asia’s leading liquidity providers. By early 2018, Amber launched their Trading Desk to offer institutional services for OTC, execution and market making. Advanced trading features are now available through Amber Pro (pro.ambergroup.io), giving institutional investors access to deep market liquidity and highly competitive, real-time pricing on-screen. The launch of the Amber App extends their crypto finance offering to a broader base of crypto users, including individual investors looking for an easy way to trade, invest, and finance crypto. The Amber App is designed to help investors achieve optimal investment returns through market-leading interest rate products, yield enhancement and risk management tools. Amber’s integrated product suite is operationally secured through robust, internal risk management controls and partnerships with third-party cryptocurrency security providers such as BitGo and Fireblocks.
About Amber Group
Amber Group is one of the world’s leading crypto finance service providers, operating 24/7 with a presence in Hong Kong, Taipei, Seoul, and Vancouver. To date, Amber Group has traded over $220B, with an average daily trading volume between $100-200M. In 2019, the Company raised $28 million in Series A funding led by Paradigm and Pantera, with participation from Polychain Capital, Dragonfly Capital, Blockchain.com, Fenbushi Capital, and Coinbase Ventures.
Newest
-
Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market
-
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
-
Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share
-
Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion